Alternatives to Science

A company focused on building and scaling innovative ventures.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing ultrasound-mediated nonviral genetic medicines.

Biofabrication platform for 3D-printed human tissue implants and future organ manufacturing.

Revolutionizing genomic analysis with innovative sequencing technology.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

DeepTech startup developing analytical tools for characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics.

Developing lightweight bionic technology.

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.

Developing a novel therapeutic approach for Alzheimer's disease.

Developing non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.

NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries.

Developing soft, stretchable brain-computer interface platforms.

Developing novel male contraceptives.

Developing a new histotripsy therapeutic platform for cancer treatment.

Develops and distributes bioreactor technology for stem cell cultivation.

Elevating uterine health through innovative biomaterial therapies.